05/15/2025
9:45 AM | Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
8:07 AM | Aclaris Therapeutics (Subject)
Adage Capital Management, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:32 PM | Aclaris Therapeutics (Issuer)
Hall Jesse Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:00 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/24/2025
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A | |
04/24/2025
6:01 AM | Aclaris Therapeutics (Filer)
| Form ARS | |
03/09/2025
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT | |
02/27/2025
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ACRS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
6:17 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
1:26 PM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:31 AM | Aclaris Therapeutics (Subject)
Adage Capital Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
6:00 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:25 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/01/2025
11:15 PM | Aclaris Therapeutics (Filer)
| Form EFFECT | |
12/31/2024
3:15 PM | Aclaris Therapeutics (Filer)
| Form 424B3 | |
12/19/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/12/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2024
7:06 AM | Aclaris Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/03/2024
4:42 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:02 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/25/2024
10:02 AM | Aclaris Therapeutics (Subject)
Biosion, Inc. (Filed by)
| Form SC 13G | |
11/25/2024
10:03 AM | Aclaris Therapeutics (Issuer)
Biosion, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
3:51 PM | Aclaris Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
11/20/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:20 PM | Aclaris Therapeutics (Issuer)
Davis Hugh M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/18/2024
7:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:21 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:18 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
10/03/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:52 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:15 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:30 PM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) So, unless you’ve been living under a rock, you probably saw the news…
Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯
We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. 🎯 Click here to watch the video and get the free ticker XGPT just flagged. |
07/31/2024
3:10 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:30 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | Aclaris Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
07/05/2024
1:46 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
12:39 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:04 PM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:30 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy ACRS Stock Free ACRS Stock Alerts